GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Total Current Assets

Changzhou Qianhong Biopharma Co (SZSE:002550) Total Current Assets : ¥1,540 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Changzhou Qianhong Biopharma Co's total current assets for the quarter that ended in Sep. 2024 was ¥1,540 Mil.


Changzhou Qianhong Biopharma Co Total Current Assets Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Total Current Assets Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,089.31 1,557.02 1,569.94 1,687.28 1,625.98

Changzhou Qianhong Biopharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,528.49 1,625.98 1,579.63 1,492.50 1,539.68

Changzhou Qianhong Biopharma Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Changzhou Qianhong Biopharma Co's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Changzhou Qianhong Biopharma Co's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Changzhou Qianhong Biopharma Co  (SZSE:002550) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Changzhou Qianhong Biopharma Co's Liquidation Value for the quarter that ended in Sep. 2024 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=708.524-277.372+0.75 * 270.788+0.5 * 390.771
=830

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changzhou Qianhong Biopharma Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.
Executives
Huang Jie Executives
Wang Ke Directors, executives
Jiang Wen Qun Supervisors
Zou Shao Bo Executives
Wei Li Jun Executives
Mei Chun Wei Executives
Zhou Xiang Directors, executives
Zhao Gang Director
Ye Hong Ping Executives
Liu Jun Director
Fan Yong Executives
Jiang Jian Ping Supervisors
Wang Yao Fang Director
Hai Tao Directors, executives
Wang Yi Director

Changzhou Qianhong Biopharma Co Headlines

No Headlines